A 38-year-old woman from rural Maharashtra presents with a 3-month history of progressive fatigue, dyspnea on exertion, and recurrent oral ulcers. On examination, she has mild hepatosplenomegaly and generalized lymphadenopathy. Laboratory investigations reveal: Hemoglobin 7.2 g/dL, WBC 2,100/μL, platelet count 65,000/μL, reticulocyte count 0.8%, and serum B12 level 180 pg/mL (normal >200). Peripheral blood smear shows hypersegmented neutrophils and macro-ovalocytes. Bone marrow examination shows hypercellular marrow with megaloblastic changes and increased iron stores. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Megaloblastic Anemia (B12 Deficiency) ### Key Clinical Features **Key Point:** The combination of pancytopenia with hypercellular marrow and megaloblastic changes is pathognomonic for megaloblastic anemia, not aplastic anemia (which shows hypocellular marrow). ### Diagnostic Workup Interpretation | Finding | Significance | |---------|-------------| | Low B12 (180 pg/mL) | Primary cause; normal >200 pg/mL | | Hypersegmented neutrophils (>5 lobes) | Hallmark of megaloblastosis | | Macro-ovalocytes on smear | Nuclear-cytoplasmic asynchrony | | Hypercellular marrow with megaloblasts | Ineffective erythropoiesis | | Low reticulocyte count (0.8%) | Impaired RBC production despite hypercellular marrow | | Increased iron stores | Rule out iron deficiency; indicates iron is not limiting | ### Mechanism of Pancytopenia in B12 Deficiency 1. B12 is essential cofactor for thymidylate synthase (DNA synthesis) 2. Defective DNA synthesis → impaired cell division across all lineages 3. Results in **ineffective hematopoiesis** — marrow is active but produces dysfunctional cells 4. Pancytopenia develops despite hypercellular marrow (distinguishes from aplasia) ### Why Marrow Is Hypercellular (Not Hypocellular) **Clinical Pearl:** In megaloblastic anemia, the marrow compensates for ineffective erythropoiesis by increasing cellularity, but most cells are destroyed intramedullary. This is **intramedullary hemolysis** — the opposite of aplastic anemia. ### Etiology in This Patient - Rural Maharashtra setting suggests dietary insufficiency (vegetarian diet, limited animal products) - 3-month insidious onset consistent with nutritional B12 deficiency - Pernicious anemia (autoimmune) would show intrinsic factor antibodies; not mentioned here **High-Yield:** Always check B12 and folate levels in any pancytopenia with hypercellular marrow. The marrow cellularity is the key discriminator from aplastic anemia. ### Next Steps in Management 1. Confirm diagnosis: Serum methylmalonic acid and homocysteine (both elevated in B12 deficiency) 2. Determine etiology: Intrinsic factor antibodies, parietal cell antibodies (pernicious anemia), dietary history, terminal ileum biopsy if needed 3. Treatment: B12 supplementation (IM cyanocobalamin 1000 μg weekly × 6 weeks, then monthly maintenance) 4. Monitor: Reticulocyte count should rise within 3–5 days of starting B12; Hb should normalize in 4–6 weeks [cite:Harrison 21e Ch 110]